Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 5/20 | 0.54 |
| ▸ | AR | P10275 | 2/20 | 0.53 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.47 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.47 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20022130 | 1.00 | SCN9A (0.54) | SCN9AARPDK2TRPA1HSD11B1 | |
| SCHEMBL5540262 | 0.96 | SCN9A (0.53) | SCN9AARPDK2TRPA1HSD11B1 | |
| SCHEMBL20022111 | 0.95 | AR (0.51) | SCN9AARPDK2TRPA1HSD11B1 | |
| SCHEMBL30146607 | 0.85 | SCN9A (0.59) | SCN9AARTRPA1HSD11B1BACE1 | |
| SCHEMBL5114438 | 0.82 | AR (0.51) | SCN9AARPDK2TRPA1HSD11B1 | |
| SCHEMBL27874356 | 0.81 | PDK2 (0.48) | SCN9AARPDK2TRPA1ENPP1 | |
| SCHEMBL27638539 | 0.81 | AR (0.59) | ARPDK2HSD11B1PTPN5 | |
| SCHEMBL6254521 | 0.79 | AR (0.43) | SCN9AARPDK2TRPA1HSD11B1 | |
| SCHEMBL25011712 | 0.78 | CYP2C9 (0.50) | SCN9AARPDK2ENPP1PTPN5 | |
| SCHEMBL29890197 | 0.78 | AR (0.48) | ARPDK2HSD11B1ENPP1PTPN5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136341-B2 | Polycyclic aromatic compound and light emission layer-forming composition | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2021-10-05 | — | — | US | disclosed |
| US-10689402-B2 | Polycyclic aromatic compound and light emission layer-forming composition | JNC CORPORATION (JP) | 2020-06-23 | — | — | US | disclosed |
| US-20200190116-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-06-18 | — | — | US | disclosed |
| US-20180094000-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2018-04-05 | — | — | US | disclosed |
| US-20180094000-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2018-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190116-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | TYR, NOD2, AHR | SCN9A 2866/4885AR 1475/4885PDK2 4751/4885 |
| US-11136341-B2 | Polycyclic aromatic compound and light emission layer-forming composition | TYR, NOD2, AHR | SCN9A 2866/4885AR 1475/4885PDK2 4751/4885 |
| US-20180094000-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION | TYR, NOD2, AHR | SCN9A 2866/4885AR 1475/4885PDK2 4751/4885 |
| US-10689402-B2 | Polycyclic aromatic compound and light emission layer-forming composition | TYR, NOD2, AHR | SCN9A 2866/4885AR 1475/4885PDK2 4751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.